Following a CHF 2.4 million seed round, Aseptuva progressed to preclinical validation
18.09.2026
Last year Swiss-UK Medtech startup Aseptuva raised CHF 2.4 million from prominent healthcare entrepreneurs and investors. The financing has enabled Aseptuva to progress from early prototyping to preclinical validation in Europe.